Penumbra Inc
PEN- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001321732
No open-market purchases or sales by Penumbra Inc insiders were filed in the last 90 days; 451 institutions reported holding it in 13F filings for Q2 2026, worth $10.8B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Penumbra Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Penumbra Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Narayan Shruthi | President | 32,650 | Sep 17, 2026 | 7 |
| Elsesser Adam | CEO | 683,042Indirect | May 21, 2026 | 1 |
| Grewal Harpreet | Director | 8,719 | Apr 6, 2026 | 6 |
| Roberts Johanna | EVP, Gen. Counsel & Secretary | 67,298 | Mar 17, 2026 | 9 |
| Yuen Maggie | Chief Financial Officer | 18,167 | Mar 17, 2026 | 5 |
| Shiu Lambert | Chief Accounting Officer | 39,323 | Mar 17, 2026 | 4 |
| Wilder Thomas | Director | 589 | Feb 18, 2026 | 3 |
| Bose Arani | Director | 1,147 | Feb 18, 2026 | 4 |
| O'Rourke Bridget | Director | 5,962 | Feb 18, 2026 | 1 |
| Leeds Janet | Director | 6,639 | Feb 18, 2026 | 1 |
| Sarna Surbhi | Director | 4,293 | Feb 18, 2026 | 1 |
| Kassing Don W. | Director | 1,409 | Feb 19, 2025 | 0 |
| Rothman Lynn | EVP and Chief Business Officer | 32,637 | Oct 5, 2021 | 0 |
| Pray James Robert | President, International | 408,431Indirect | Oct 5, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 (view filing) | Sep 2 | 2 days | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −600 | $270.58 | −$162.3K | −0.9%64.9K after | 5 lots10b5-1 |
| Oct 3, 2025 (view filing) | Oct 2 | 1 day | Grewal HarpreetDirector | SSale | −186 | $248.61 | −$46.2K | −2.1%8.70K after | 10b5-1 |
| Oct 3, 2025 (view filing) | Oct 1 | 2 days | Wilder ThomasDirector | SSale | −186 | $253.93 | −$47.2K | −50.0%186 after | 10b5-1 |
| Oct 3, 2025 (view filing) | Oct 1 | 2 days | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −600 | $249.70 | −$149.8K | −0.9%64.3K after | 13 lots10b5-1 |
| Nov 6, 2025 (view filing) | Nov 4 | 2 days | Grewal HarpreetDirector | SSale | −186 | $227.58 | −$42.3K | −2.1%8.52K after | 10b5-1 |
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −600 | $266.98 | −$160.2K | −0.9%63.7K after | 7 lots10b5-1 |
| Nov 25, 2025 (view filing) | Nov 21 | 4 days | Bose AraniDirector | SSale | −7.50K | $290.56 | −$2.18M | −2.6%282.8K after | 2 lots10b5-1 |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Bose AraniDirector | SSale | −7.50K | $300.19 | −$2.25M | −2.7%275.3K after | 10b5-1 |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −1.80K | $300.06 | −$540.1K | −2.7%64.7K after | 10b5-1 |
| Dec 3, 2025 (view filing) | Dec 2 | 1 day | Grewal HarpreetDirector | SSale | −100 | $292.98 | −$29.3K | −1.2%8.42K after | 10b5-1 |
| Dec 3, 2025 (view filing) | Dec 1 | 2 days | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −600 | $294.94 | −$177.0K | −0.9%64.1K after | 7 lots10b5-1 |
| Dec 9, 2025 (view filing) | Dec 5 | 4 days | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −300 | $300.13 | −$90.0K | −0.5%63.8K after | 10b5-1 |
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | Bose AraniDirector | SSale | −15.0K | $308.82 | −$4.63M | −5.5%258.5K after | 7 lots10b5-1 |
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Wilder ThomasDirector | SSale | −186 | $310.72 | −$57.8K | −100.0%0 after | 10b5-1 |
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Grewal HarpreetDirector | SSale | −186 | $312.64 | −$58.2K | −2.2%8.23K after | 10b5-1 |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Yuen MaggieChief Financial Officer | SSale | −2.43K | $342.30 | −$832.5K | −11.7%18.4K after | 10b5-1 |
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Grewal HarpreetDirector | SSale | −100 | $328.22 | −$32.8K | −1.1%8.72K after | 10b5-1 |